The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD
2020 · Modern Rheumatology · 549 citations
https://doi.org/10.1080/14397595.2020.1859710
Y
Yasuharu Sato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
297
Papers
11.9K
Citations
47
h-index
150
i10-index
Yasuharu Sato is an academic researcher from Okayama University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders & IgG4-Related and Inflammatory Diseases. The author has an h-index of 47, co-authored 253 publications.
ORCID: 0000-0001-5234-6861Papers by this author
worksClinicopathologic analysis of <scp>TAFRO</scp> syndrome demonstrates a distinct subtype of <scp>HHV</scp>‐8‐negative multicentric Castleman disease
2015 · American Journal of Hematology · 273 citations
https://doi.org/10.1002/ajh.24242
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
2019 · Leukemia · 144 citations
https://doi.org/10.1038/s41375-019-0380-5
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric <scp>Castleman</scp> disease
2021 · American Journal of Hematology · 115 citations
https://doi.org/10.1002/ajh.26292
TAFRO Syndrome
2017 · Hematology/Oncology Clinics of North America · 56 citations
https://doi.org/10.1016/j.hoc.2017.09.009
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
2023 · Leukemia · 56 citations
https://doi.org/10.1038/s41375-023-01962-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat